ated with time to initiate heavy drinking (adjusted relative hazard (ARH) 1.27; 95% CI 0.78-2.07) after adjustment for relevant demographic and substance-use characteristics. Age and cannabis use were the only variables that were independently associated with the time to onset of heavy drinking (ARH 0.74; 95% CI 0.58-0.94 and ARH 2.06; 95% CI 1.32-3.19, respectively). Conclusion: In this study, MMT enrolment did not predict heavy drinking and may even appear to decrease the initiation of heavy drinking. Our findings suggest younger age and cannabis use may predict heavy drinking. These findings could help inform on-going discussions about the effects of opioid agonist therapy on alcohol consumption among people who use heroin.
Introduction
Heroin use continues to drive mental and physical morbidity and mortality globally and frequently goes along with concomitant substance use disorders [1, 2] . Methadone maintenance therapy (MMT) has been shown to reduce morbidity and mortality among people who use heroin and other opiates [3, 4] ; however, previous studies have suggested a high prevalence of heavy alcohol use among MMT patients [5] [6] [7] , and interventions to reduce heavy drinking in this population are lacking [8] . MMT patients who engage in heavy alcohol use do not appear to benefit from MMT to the same extent as those who do not, and most of them develop further complications [9] [10] [11] . Many patients overdose because of alcohol [12, 13] . While recent systematic reviews have indicated that alcohol, heroin and methadone are correlated, the impact of enrolment in MMT on heavy drinking has not been fully characterized [5, 14, 15] . Phases of heavy drinking seem to follow after bouts of abstinence from heroin use, and this pattern often repeats over time [16] . However, specifics of this relationship remain unclear. Therefore, we undertook this longitudinal study to examine whether the enrolment in MMT was associated with the initiation of heavy alcohol use among people who use heroin who were not engaged in heavy alcohol use or enrolled in MMT at baseline.
Methods
We obtained data for this analysis from 2 prospective cohorts of people who use drugs in Vancouver, Canada: the Vancouver Injection Drug Users Study (VIDUS) and the AIDS Care Cohort to Evaluate Exposure to Survival Services (ACCESS). These cohorts have been described elsewhere [17] [18] [19] . Briefly, VIDUS is a cohort of HIV-seronegative adults who have injected an illicit drug in the month prior to the baseline interview. ACCESS enrolls HIVseropositive adult drug users who have used an illicit drug other than cannabis in the previous month at baseline. Both cohorts recruit through snowballing and street outreach. Both cohorts use harmonized questionnaires at baseline and bi-annually thereafter that include demographic characteristics, drug use patterns and related exposures. The follow-up assessments were conducted approximately every 6 months. The missed assessments were managed as missing values in the data analysis. Serologic testing for HIV and HCV antibodies, and HIV disease monitoring, as appropriate, is also conducted. To compensate participants for their time, a $30 CDN stipend was given at each interview. The University of British Columbia/Providence Healthcare Research Ethics Board approved both studies, and all respondents signed an informed consent at baseline.
The present study included participants who (1) were recruited between December 1, 2005, and May 31, 2014, and have had at least 1follow-up visit; (2) reported having ever injected drugs at baseline; (3) reported any heroin use in the past 6 months at baseline; (4) reported not being enrolled in MMT in the past 6 months at baseline and (5) did not report the National Institute on Alcohol Abuse and Alcoholism (NIAAA)-defined heavy alcohol use in the past 6 months at baseline. NIAAA defines heavy alcohol use as an average of >3 drinks per occasion, or >7 drinks per week, among females, and an average of >4 drinks per occasion, or >14 drinks per week, among males [20] .
The primary end point was time to initiation of NIAAA-defined heavy alcohol use. The date of initiation was estimated using the midpoint between the last negative and the first affirmative reports of heavy alcohol use in the previous 6 months before baseline or a follow-up assessment. The primary explanatory variable of interest was the enrolment in MMT in the previous 6 months before a follow-up assessment. We also selected other demographic, behavioral and health characteristics as secondary explanatory variables based on previous studies that identified potential predictors of changes in alcohol consumption in relation to addiction treatment [21] [22] [23] [24] . These included: age (per year older); gender (male vs. female); ethnicity/ancestry (Caucasian vs. aboriginal vs. others); baseline depression, as measured by the Center for Epidemiologic Studies Depression Scale (CES-D) (CES-D score of ≥ 22 vs. <22) and drug-using behavior in the past 6 months before baseline or a follow-up assessment, including heroin injection ( ≥ daily vs. <daily), cannabis use ( ≥ daily vs. <dai-ly), cocaine/crack use ( ≥ daily vs. <daily) and benzodiazepine use (yes vs. no).
We used an extended Cox model to examine bivariable and multivariable associations between the explanatory variables and the time to initiate heavy alcohol use. Age, MMT enrolment, HIV serostatus and all drug-using behavior were treated as time varying variables. To make sure that all these factors preceded the estimated initiation of heavy drinking, these time varying variables were lagged by one follow-up assessment and referred to the 6 months prior to the follow-up questionnaire(s) up until one immediately preceding the first report of heavy drinking. All explanatory variables were included in the multivariable model. All p values were 2-sided. All statistical analyses were performed using the SAS software version 9.3 (SAS, Cary, N.C., USA).
Results
A total of 357 participants were eligible for this analysis and followed for a median of 50.3 months (interquartile range 16.2-86.2). Of those, 251 (70%) were male, and 212 (59%) were Caucasian ( table 1 ) . At baseline, 210 (59%) reported daily injection heroin use in the past 6 months and 180 (50%) had CES-D scores of ≥ 22. In total, 208 (58%) initiated MMT during follow-up. The groups in-and out-of the MMT were comparable at baseline, except for gender, depression, heroin, cannabis and cocaine/crack use. In the overall sample, a total of 115 (32%) people initiated heavy alcohol use for an incidence density of 7.8 events (95% CI 6.4-9.5) per 100 personyears. Among those with no MMT enrolment throughout follow-up, the incidence density was 16.2 events (95% CI 12.1-21.6) per 100 person-years, whereas it was 4.6 events (95% CI 3.5-6.1) per 100 person-years among those reporting enrolment in MMT at least at one follow-up visit. The difference was statistically significant with p value of <0.001. Table 2 shows the results of bivariable and multivariable extended Cox regression analyses. As shown, MMT enrolment was not significantly associated with heavy drinking in bivariable (relative hazard (RH) 1.26; 95% CI 0.80-1.98) or multivariable analyses (adjusted RH (ARH) 1.27; 95% CI 0.78-2.07). Age and cannabis use were the only variables that were independently associated with the time to onset of heavy drinking (ARH 0.74; 95% CI 0.58-0.94 and ARH 2.06; 95% CI 1.32-3.19, respectively) after adjustment for relevant demographic and substance use characteristics.
Discussion
In this study, enrolment in MMT was not associated with heavy drinking among our cohort of people who used heroin. Previous studies have found mixed results regarding the substitution of one substance (heroin) for another (alcohol) upon enrolment in MMT. While some suggested that such substitution occurred, others did not [14, 15, 23] . One could speculate that the substitution hypothesis holds only for people who actively seek treatment and, who therefore, may have greater severity of health-or drug-related problems, including drinking. However, our findings suggest that it is younger age, rather than treatment seeking behavior, that may be associated with initiation of heavy drinking among people who use heroin. Inclusion into MMT may even decrease the initiation of heavy drinking. Such findings are consistent with previous research [24] . Although stimulants (cocaine), and other drugs, including cannabis and benzodiazepines, have been previously found to be potential predictors of changes in alcohol consumption [5] , our research confirmed this for cannabis only. Irrespective of the reasons for heavy drinking, our study confirmed a high prevalence of this problem (32%); therefore, the na- 213 tional guidelines and policies should give clear guidance about the management of concurrent heavy drinking among this population. More research should be conducted to help inform decisions regarding strategies for addressing heavy drinking among people who use heroin, including screening, brief intervention, referral to treatment or medication assisted therapy, as part of MMT.
We note several limitations of our research. First, our conclusions may not be generalizable, because our cohorts are non-randomized samples. Second, self-reported data may be subject to response bias, although the argument against the validity of such data has been shown to be overstated [25] . Third, similar to all observational studies, the relationships between the independent and outcome variables may be under the influence of unobserved confounding. Lastly, although we did not confirm the heavy drinking by objective measures, such as breath or urine ethyl glucuronide tests, such measures detect recent drinking only and are not considered the gold standard without the complementary self-report methods [26, 27] . Future research should also explore the contribution of HIV-related clinical characteristics to the relationship between drinking and opioid agonist treatment among PWID living with HIV.
In summary, we did not find that enrolment in MMT was associated with initiation of heavy alcohol use among people who used heroin, and who were not engaged in heavy alcohol use, or enrolled in MMT, at baseline. The 'substitution' controversy (alcohol for heroin) was not confirmed. Future prospective analyses should also examine the second key controversy in this field, that is, whether heavy drinking post-MMT leads to a relapse to one's primary drug problem. The funders had no role in the design and conduct of the study; the collection, analysis and interpretation of the data; the preparation of the manuscript or the decision to submit the manuscript for publication.
